Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-02 · accession 0001048477-24-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-02 | BMRN | Davis George Eric | EVP, CLO | S - Sale+OE | $85.01 | -1,850 | 56.2K | -3% | -$157.3K |
| D | 2024-05-06 | 2024-04-30 | BMRN | Davis George Eric | EVP, CLO | A - Grant | $68.65 | +301 | 56.2K | +0.5% | +$20.7K |
| D | 2024-05-06 | 2024-05-02 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $63.10 | +1,850 | 58.0K | +3% | +$116.7K |
| D | 2024-05-06 | 2024-05-02 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $0.00 | -1,850 | 40.9K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | S | D | 1,850 | $85.01 | 56,157 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. (F3) The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.00 to $85.03. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |
| 2 | Common | Common Stock | 2024-04-30 | A | A | 301 | $68.65 | 56,157 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2024-05-02 | M | A | 1,850 | $63.10 | 58,007 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on September 13, 2023. |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2024-05-02 | M | D | 1,850 | $0.00 | 40,850 | D | $63.10 · 2014-12-04 to 2024-06-30 | 1,850 Common Stock | (F4) Reflects the number of options outstanding after the transactions from this specific stock option grant. |